Proto Labs, Inc. (PRLB) Bundle
Understanding Proto Labs, Inc. (PRLB) Revenue Streams
Understanding Proto Labs, Inc.’s Revenue Streams
Proto Labs, Inc. generates revenue through various manufacturing services, primarily in the areas of injection molding, CNC machining, 3D printing, and sheet metal fabrication. The company has reported the following revenue figures for the third quarter of 2024:
| Revenue Source | Q3 2024 Revenue (in thousands) | Q3 2023 Revenue (in thousands) | Year-over-Year Change (%) |
|---|---|---|---|
| Injection Molding | $46,831 | $51,688 | -9.4% |
| CNC Machining | $53,327 | $52,916 | 0.8% |
| 3D Printing | $21,437 | $21,622 | -0.9% |
| Sheet Metal | $3,743 | $4,291 | -12.8% |
| Other Revenue | $281 | $188 | 49.5% |
| Total Revenue | $125,619 | $130,705 | -3.9% |
For the nine months ended September 30, 2024, the total revenue was reported at $379,140,000, a slight increase of 0.1% compared to $378,829,000 for the same period in 2023.
Year-over-Year Revenue Growth Rate
The year-over-year revenue growth rate shows a mixed performance across different segments. The overall revenue for the third quarter of 2024 decreased by 3.9% compared to the same quarter in 2023. The significant contributors to this decline include:
- Injection Molding: -9.4%
- Sheet Metal: -12.8%
- 3D Printing: -0.9%
Conversely, CNC Machining experienced a modest increase of 0.8%, and Other Revenue surged by 49.5%.
Contribution of Different Business Segments to Overall Revenue
The contribution of various segments to total revenue for the third quarter of 2024 is as follows:
| Business Segment | Revenue Contribution (in thousands) | Percentage of Total Revenue (%) |
|---|---|---|
| Injection Molding | $46,831 | 37.3% |
| CNC Machining | $53,327 | 42.4% |
| 3D Printing | $21,437 | 17.1% |
| Sheet Metal | $3,743 | 3.0% |
| Other Revenue | $281 | 0.2% |
| Total Revenue | $125,619 | 100% |
Analysis of Significant Changes in Revenue Streams
The most notable changes in revenue streams include:
- The decline in Injection Molding and Sheet Metal revenue, which are traditional strongholds for the company, indicating potential challenges in these segments.
- The growth in Other Revenue, highlighting the diversification of revenue sources.
As the company continues to adapt to market conditions, the revenue from CNC Machining remains stable, indicating resilience in that segment amidst overall declines.
A Deep Dive into Proto Labs, Inc. (PRLB) Profitability
A Deep Dive into Proto Labs, Inc.'s Profitability
Gross Profit: For the third quarter of 2024, gross profit was $57,230 thousand, down from $59,282 thousand in the third quarter of 2023. Over the nine months ended September 30, 2024, gross profit stood at $171,243 thousand compared to $166,181 thousand for the same period in 2023.
Operating Profit: The income from operations for Q3 2024 was $8,580 thousand, decreasing from $10,415 thousand in Q3 2023. For the nine months ended September 30, 2024, operating income increased to $21,406 thousand from $19,772 thousand in the prior year.
Net Profit: Net income for Q3 2024 was $7,189 thousand, compared to $7,954 thousand in Q3 2023. For the nine months ended September 30, 2024, net income was $16,997 thousand, up from $10,230 thousand in 2023.
| Metric | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Gross Profit ($000) | 57,230 | 59,282 | 171,243 | 166,181 |
| Operating Income ($000) | 8,580 | 10,415 | 21,406 | 19,772 |
| Net Income ($000) | 7,189 | 7,954 | 16,997 | 10,230 |
Profit Margins: The GAAP gross margin for Q3 2024 was 45.6%, slightly up from 45.4% in Q3 2023. The non-GAAP gross margin was 46.2% compared to 46.0% in the prior year. The GAAP operating margin for Q3 2024 was 6.8%, down from 8.0% in Q3 2023, while the non-GAAP operating margin decreased to 10.9% from 12.5%.
Trends in Profitability Over Time: Over the past year, gross profit has shown a declining trend in quarterly results, while net income has improved year-to-date despite fluctuations in quarterly performance. The operating profit reflects a similar pattern of decline in the most recent quarter compared to the previous year.
Comparison with Industry Averages: As of 2024, the company’s gross margin of 45.6% is competitive within the manufacturing sector, where average gross margins typically range between 40% and 50%. The operating margin of 6.8% remains below the industry average, which often sits around 10% to 15%.
Operational Efficiency: The company has focused on cost management, reflected in its operating expenses, which totaled $48,650 thousand in Q3 2024, slightly reduced from $48,867 thousand in Q3 2023. The gross margin trend shows a modest improvement, indicating effective cost control measures amidst revenue challenges.
| Operating Expenses Breakdown ($000) | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Marketing and Sales | 22,619 | 21,682 | 69,070 | 65,863 |
| Research and Development | 9,772 | 10,105 | 31,600 | 30,647 |
| General and Administrative | 16,259 | 17,058 | 49,167 | 49,713 |
| Total Operating Expenses | 48,650 | 48,867 | 149,837 | 146,409 |
Debt vs. Equity: How Proto Labs, Inc. (PRLB) Finances Its Growth
Debt vs. Equity: How Proto Labs, Inc. Finances Its Growth
The financial structure of Proto Labs, Inc. involves a careful balance between debt and equity financing to support its growth strategy. As of September 30, 2024, the company reported the following debt levels:
- Current Liabilities: $53.76 million
- Long-term Liabilities: $19.01 million
Total liabilities, including both current and long-term, amounted to $753.79 million. The shareholders' equity was reported at $679.99 million, indicating a robust equity base to support ongoing operations and investments.
The debt-to-equity ratio, a crucial metric for understanding financial leverage, is calculated as follows:
| Metric | Amount (in millions) |
|---|---|
| Total Debt | $53.76 (current) + $19.01 (long-term) = $72.77 |
| Shareholders' Equity | $679.99 |
| Debt-to-Equity Ratio | 0.107 |
This debt-to-equity ratio of 0.107 is significantly lower than the industry average, which typically hovers around 0.5 to 1.0. This indicates that Proto Labs relies more on equity financing than debt, reflecting a conservative approach to leveraging.
In recent months, Proto Labs has engaged in financing activities to optimize its capital structure. The company has not issued new long-term debt but has focused on maintaining its existing obligations, with no recent downgrades in credit ratings noted, suggesting a stable financial outlook. The company’s liquidity position is strengthened by cash and cash equivalents amounting to $87.87 million as of September 30, 2024.
Proto Labs balances its financing strategy by utilizing both debt and equity. The low level of debt allows the company to maintain financial flexibility, enabling it to invest in growth opportunities without the burden of high-interest payments. This strategy supports its goal of expanding its manufacturing capabilities while minimizing financial risk.
Overall, Proto Labs demonstrates a prudent approach to debt and equity financing, characterized by low leverage and a strong equity position, which is essential for sustaining its growth trajectory in the competitive digital manufacturing sector.
Assessing Proto Labs, Inc. (PRLB) Liquidity
Assessing Proto Labs, Inc.'s Liquidity
Current and Quick Ratios
The current ratio for Proto Labs, Inc. as of September 30, 2024, stands at 3.59, calculated by dividing total current assets of $193,074,000 by total current liabilities of $53,758,000. The quick ratio, which excludes inventory from current assets, is 3.24, derived from current assets of $193,074,000 minus inventory of $12,415,000, divided by current liabilities of $53,758,000.
Analysis of Working Capital Trends
Working capital for Proto Labs, Inc. as of September 30, 2024, is calculated as current assets minus current liabilities, resulting in $139,316,000. This figure reflects a decrease from the previous period, where the working capital was $150,979,000 as of December 31, 2023. The decline indicates a tightening of liquidity, despite still maintaining a strong working capital position.
Cash Flow Statements Overview
For the nine months ended September 30, 2024, the cash flow from operating activities was $60,535,000, compared to $56,046,000 for the same period in 2023. Investing activities showed a net cash usage of $10,683,000 in 2024, while financing activities resulted in a cash outflow of $46,004,000. This indicates a robust generation of cash from operations, which is critical for maintaining liquidity.
Potential Liquidity Concerns or Strengths
Despite the strong current and quick ratios, the decrease in working capital trends and the significant cash outflow from financing activities, primarily due to stock repurchases of $45,958,000, could signal potential liquidity concerns. However, the company's ability to generate cash from operations remains a strength, evidenced by the highest quarterly operating cash flow since 2020 of $24,800,000 in Q3 2024.
| Liquidity Metric | Value |
|---|---|
| Current Ratio | 3.59 |
| Quick Ratio | 3.24 |
| Working Capital (Sept 30, 2024) | $139,316,000 |
| Cash Flow from Operating Activities (2024) | $60,535,000 |
| Cash Flow from Investing Activities (2024) | ($10,683,000) |
| Cash Flow from Financing Activities (2024) | ($46,004,000) |
| Quarterly Operating Cash Flow (Q3 2024) | $24,800,000 |
Is Proto Labs, Inc. (PRLB) Overvalued or Undervalued?
Valuation Analysis
To determine whether Proto Labs, Inc. is overvalued or undervalued, we will analyze key financial ratios, stock performance, and analyst sentiments.
Price-to-Earnings (P/E) Ratio
The P/E ratio is calculated as:
P/E Ratio = Stock Price / Earnings Per Share (EPS)
As of November 1, 2024, the stock price was approximately $12.75. The GAAP EPS for Q3 2024 was $0.29, leading to:
P/E Ratio = $12.75 / $0.29 = 43.97
Price-to-Book (P/B) Ratio
The P/B ratio is calculated as:
P/B Ratio = Stock Price / Book Value per Share
As of September 30, 2024, total shareholders' equity was $679,993,000 with 25,022,485 diluted shares outstanding:
Book Value per Share = $679,993,000 / 25,022,485 = $27.19
P/B Ratio = $12.75 / $27.19 = 0.47
Enterprise Value-to-EBITDA (EV/EBITDA) Ratio
The EV/EBITDA ratio is calculated as:
EV = Market Capitalization + Total Debt - Cash and Cash Equivalents
Market Capitalization = Stock Price Shares Outstanding = $12.75 25,022,485 = $319,527,000
Total Debt (as of September 30, 2024) was $3,935,000 and Cash and Cash Equivalents were $87,873,000:
EV = $319,527,000 + $3,935,000 - $87,873,000 = $235,589,000
EBITDA for Q3 2024 was $17,490,000:
EV/EBITDA = $235,589,000 / $17,490,000 = 13.47
Stock Price Trends
Over the last 12 months, the stock price has shown the following trends:
- 12 months ago: Approximately $16.00
- Current Price: Approximately $12.75
- Percentage Decrease: 20.4%
Dividend Yield and Payout Ratios
As of November 1, 2024, the company does not pay a dividend, resulting in a dividend yield of:
Dividend Yield = 0%
Analyst Consensus on Stock Valuation
As of the latest reports, the consensus among analysts is as follows:
- Buy: 2
- Hold: 5
- Sell: 1
| Metric | Value |
|---|---|
| P/E Ratio | 43.97 |
| P/B Ratio | 0.47 |
| EV/EBITDA Ratio | 13.47 |
| Current Stock Price | $12.75 |
| 12-Month Stock Price Change | -20.4% |
| Dividend Yield | 0% |
| Analyst Consensus | Buy: 2, Hold: 5, Sell: 1 |
Key Risks Facing Proto Labs, Inc. (PRLB)
Key Risks Facing Proto Labs, Inc. (PRLB)
Proto Labs faces a variety of internal and external risks that could impact its financial health, particularly in a competitive manufacturing landscape. These risks encompass industry competition, regulatory changes, and fluctuating market conditions.
Industry Competition
The manufacturing sector is characterized by intense competition. For the third quarter of 2024, total revenue decreased by 3.9% to $125.6 million, compared to $130.7 million in the same quarter of 2023. This decline highlights the pressure from competitors and the need for continuous innovation and differentiation in service offerings.
Regulatory Changes
Regulatory changes can affect operational costs and compliance requirements. As of September 30, 2024, the company reported total liabilities of $73.8 million, including current liabilities of $53.8 million. Increased regulatory scrutiny could lead to higher costs associated with compliance and operational adjustments.
Market Conditions
Market conditions, including economic downturns and fluctuations in demand, pose significant risks. For example, revenue from injection molding dropped by 9.4% year-over-year, indicating potential weaknesses in market demand for specific services. The company's reliance on certain market segments could lead to vulnerabilities if those segments experience downturns.
Operational Risks
Operational risks include challenges in maintaining efficient production processes. The company reported operating expenses of $48.7 million in Q3 2024, slightly down from $48.9 million in the previous year. Any disruptions in manufacturing or supply chain could adversely affect operational performance and profitability.
Financial Risks
Financial risks stem from market volatility and foreign currency fluctuations. The company recognized an unrealized foreign currency loss of $174,000 in Q3 2024. Such fluctuations can impact revenue and profit margins, necessitating careful financial management strategies.
Strategic Risks
Strategic risks involve the potential for misalignment between company initiatives and market needs. The recent restructuring aimed at better positioning the company for growth could lead to short-term disruptions. The company’s net income for the third quarter of 2024 was $7.2 million, down from $8.0 million in the same quarter of 2023. This drop may impact investor confidence and stock performance.
Mitigation Strategies
Proto Labs has implemented various strategies to mitigate these risks. The company has focused on enhancing its operational efficiency and expanding its service offerings to remain competitive. For instance, cash flow from operations reached $24.8 million in Q3 2024, indicating strong operational performance despite challenges. Additionally, the company maintains a cash and investments balance of $117.6 million, providing a buffer against unforeseen financial pressures.
| Risk Type | Description | Financial Impact (Q3 2024) |
|---|---|---|
| Industry Competition | Revenue decline due to competitive pressures | $125.6 million (down 3.9% YoY) |
| Regulatory Changes | Increased compliance costs | Total Liabilities: $73.8 million |
| Market Conditions | Fluctuations in demand affecting revenue | Injection Molding Revenue: $46.8 million (down 9.4% YoY) |
| Operational Risks | Challenges in production efficiency | Operating Expenses: $48.7 million |
| Financial Risks | Impact of foreign currency fluctuations | Foreign Currency Loss: $174,000 |
| Strategic Risks | Potential misalignment with market needs | Net Income: $7.2 million (down from $8.0 million YoY) |
Future Growth Prospects for Proto Labs, Inc. (PRLB)
Future Growth Prospects for Proto Labs, Inc. (PRLB)
Key Growth Drivers:
- Product Innovations: Development of advanced manufacturing technologies, including enhancements in 3D printing capabilities.
- Market Expansions: Geographic expansion into Europe and Asia, targeting increased market share.
- Acquisitions: Integration of 3D Hubs has expanded service offerings and customer base.
Future Revenue Growth Projections and Earnings Estimates:
| Period | Projected Revenue (in millions) | Projected Earnings Per Share (EPS) |
|---|---|---|
| Q4 2024 | $115 - $123 | $0.10 - $0.18 |
| 2024 (Full Year) | $494.14 | $1.26 |
Strategic Initiatives or Partnerships:
- Investments in Digital Manufacturing: Committed to investing profits to enhance production capabilities.
- Partnerships with Supply Chain Networks: Leveraging relationships to streamline operations and improve service delivery.
Competitive Advantages:
- Unique Business Model: Combination of digital manufacturing and a vetted network of partners enhances operational efficiency.
- Strong Brand Reputation: Recognized leader in the rapid prototyping and low-volume production market.
- Robust Financial Position: Cash and investments balance of $117.6 million as of September 30, 2024.
Recent Financial Performance:
| Metric | Q3 2024 | Q3 2023 | Year-over-Year Change |
|---|---|---|---|
| Total Revenue | $125.6 million | $130.7 million | -3.9% |
| Net Income | $7.2 million | $8.0 million | -10% |
| Non-GAAP Net Income | $11.8 million | $13.2 million | -10.6% |
Customer Engagement:
- Customer Contacts: Served 22,511 customer contacts in Q3 2024, compared to 23,080 in Q3 2023.
- Revenue per Customer Contact: Decreased to $5,580 from $5,663 year-over-year.
Operational Efficiency:
- Gross Margin: Reported at 45.6% in Q3 2024, slightly up from 45.4% in Q3 2023.
- Adjusted EBITDA Margin: At 17.4% for Q3 2024, compared to 18.3% in the prior year.
Proto Labs, Inc. (PRLB) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Article updated on 8 Nov 2024
Resources:
- Proto Labs, Inc. (PRLB) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Proto Labs, Inc. (PRLB)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Proto Labs, Inc. (PRLB)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.